SCHEMBL18791007

SCHEMBL18791007

CC1CCC(c2cncc(N3CCN(CC(=O)NC(C)C)CC3)c2)CC1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TDP1 Q9NUW8 1/20 0.46
▸ CYP11B2 P19099 9/20 0.41
▸ TLR9 Q9NR96 1/20 0.40
▸ TLR8 Q9NR97 1/20 0.40
▸ TLR7 Q9NYK1 1/20 0.40
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ HTT P42858 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ PTPN11 Q06124 1/20 0.39
▸ CHRM5 P08912 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ GFER P55789 2/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RAD52 P43351 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22236820 0.85 ALDH1A1 (0.40) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL22236812 0.82 CYP11B2 (0.51) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL22236774 0.79 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL18791083 0.79 ALDH1A1 (0.52) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL18791006 0.77 CYP11B2 (0.42) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL23679948 0.74 CYP11B2 (0.53) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL23862112 0.71 CHRM5 (0.62) ALDH1A1KDM4ESMN1; SMN2TDP1MEN1
SCHEMBL18790986 0.69 CYP11B2 (0.65) ALDH1A1KDM4ESMN1; SMN2TDP1CYP11B2
SCHEMBL12890282 0.69 ALDH1A1 (0.70) ALDH1A1KDM4ESMN1; SMN2TDP1MEN1
SCHEMBL12082132 0.69 GFER (0.57) ALDH1A1KDM4ESMN1; SMN2TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound MITSUBISHI TANABE PHARMA CORPORATION (JP) 2020-07-21 — — US disclosed
WO-2017069226-A1 NOVEL NITROGEN-CONTAINING AROMATIC HETEROCYCLIC COMPOUND 田辺三菱製薬株式会社 2017-04-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10717731-B2 Nitrogen-containing aromatic heterocyclic compound REN, NR3C2, NR5A1 ALDH1A1 1495/4885KDM4E 2819/4885SMN1; SMN2 4151/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback